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  Number of patients (%) 
T stage 
pTis 
pT0 
pT1a 
pT1b
pT1c 
pT2 
pT3 
pT4b
pT4d
4 (6) 
2 (3) 
3 (4) 
24 (36) 
20 (29) 
3 (4) 
1 (1) 
2 (3) 
9 (12) 
 
Conclusions: This system based on artificial intelligence automatically 
enables the classification of tumor size in BC. Among the data mining 
algorithms, the J48 algorithm had the highest percentage of correctly 
classified cases and allows changes (i.e.: guideline updates). This tool 
would save time in the data collection, prevent errors, and improve 
tumor classification as well as the quality of the therapeutic decision.  
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Purpose/Objective: Breast conserving surgery and post-operative 
whole breast radiotherapy (RT) have proved to reduce local 
recurrence and improve survival of early stage breast cancer patients. 
On the other hand, it has been demonstrated that long-term survivors 
have a significantly higher risk of lung complications and cardiac 
death as a consequence of heart and lung irradiation during tangential 
breast RT. Respiratory gating RT provides a chance to reduce heart 
and lung doses. This study evaluates the cardiopulmonary dose sparing 
of a prospective-gating RT for left breast cancer using a four-
dimensional computed tomography (4DCT) technique.  
Materials and Methods: Patients with early left breast cancer, 
referred for adjuvant radiotherapy to our Institution,were enrolled in 
this study. For each patient, two simulation CT-scans were acquired: 
the first during free breathing and the second on prospective gating 
during deep inspiration breath-hold. The scans were monitored by the 
Varian RPMTM respiratory gating system. Whole heart and pericardium 
was contoured starting superiorly just below the left pulmonary 
artery. For each patient, two treatment plans, based on the two CT 
studies, were performed with conformal tangential fields. Maximum 
lung distance (MLD) was measured on beams eye view. Mean heart 
dose (MHD), heart V25, ipsilateral lung V20 and V30 were evaluated. 
Dose-volume histograms were calculated and compared by the paired 
sample T-test. 
Results:  
 From January to November 2012, 71 patients were enrolled. Median 
age was 50 years (range 30-76),the mean breathing period was 4.3s 
(range 2-12.9), and the mean 4DCT scanning time was 12.2 s (range 5-
19). Overall patients’ compliance was good The average MHD was 3.2 
Gy (range 0.90-8.70) in the 4D plans and 1.8 Gy (range 0.50-4.70) in 
the 3D plans (p<0.0001). The mean heart V25 was 2.25% (range 0-
12.60) and 0.14% (range 0-3.40) for 3D and 4D plans, respectively 
(p<0.0001). The average MLD was 2.17 cm (range 0.97-3.74) on 3D 
plans and 2.43 cm (range 1.25-4.0) on the 4D plans (p<0.0001). The 
mean lung V20 and V30 were 11.28% (range 1.70-27.50) and 9.37% 
(range 1.10-24.80) for 3D plans, and 9.25 % (range3.50-20.60) and 
7.89% (range 2.40-30) for 4D plans (p<0.0001 and p=0.0035, 
respectively).  
Conclusions: Prospective gating tangential RT to left breast allows the 
delivery of a significantly lower dose to heart. The MLD was 
significantly higher on 4D plans, but the ipsilateral lung received an 
overall smaller dose of RT, as demonstrated by the significantly lower 
V20 and V30.  
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Purpose/Objective: The aim of this prospective study is to evaluate 
feasibility, early and late skin toxicity in women treated with 
hypofractionated whole breast irradiation schedule for breast cancer. 
Materials and Methods: Between 2/ 2008 and 4/ 2011, 40 women 
with invasive early breast cancer were treated with conservative 
surgery followed by sentinel-node biopsy in 47.5% and axillary 
dissection in 40%. No axillary node surgery was performed in 12.5% of 
cases. The median age was 72 years (range 56-85). Hystology was as 
follows: infiltrating ductal carcinoma 30/40 pts , infiltrating lobular 
carcinoma 6/40 pts, CDI and CLI 1/40 pt, others 3/40 pts. Stage was 
as follows: pT1 in 33 pts (82.5%), pT2 in 7 pts (17.5%). The axillary 
lymph nodes were negative in 77.5% and positive (pN1a) in 12.5% . 
Thirty-five pts received adjuvant hormone therapy and 3 pts received 
adjuvant systemic therapy respectively. Radiation therapy was 
delivered by means of two opposed tangential fields. Using the 
original planning computer tomography scans the entire breast and 
OARs were delineated. The DVH histograms were accepted just if PTV 
was included in ICRU constraints. All pts were treated with 6-15 MV x-
rays. Median whole-breast irradiation dose prescribed was 40.05Gy 
(range: 40 - 42.5 Gy) administered in 15-16 fractions of 2.5-2.67Gy (5 
fractions/week). Boost irradiation to the tumor bed with the doses of 
2 to 3 Gy/fraction was performed in 4 cases. No attempt was made to 
treat the axilla or the supraclavicular or internal mammary nodes. 
Results: All pts completed the schedule. The median follow-up was 18 
months (range 16-54 months). All pts were routinely evaluated to 
register acute side effects and late skin toxicity according to RTOG 
criteria. At the end of treatment 50% presented grade 0 acute skin 
toxicity, 35% had grade 1 and 15% had grade 2. At 6 months there 
were 30% cases of grade 1 skin toxicity and 7.5% of grade 2. At 12 
months 45% and 5 % of pts presented with clinical grade 1 and grade 2 
fibrosis respectively and 5% presented hyperpigmentation. At 24 
months, with 21 patients evaluated, just 1 pt showed grade 2 late 
fibrosis. The remaining pts were free of side effects. No pts 
experienced local relapse, nor distant metastasis. 
Conclusions: Our data showed a good feasibility of the 
hypofractionated schedule in terms of acute and late skin toxicity. 
The hypofractionated schedule shortens the overall treatment time 
and represents a biologically acceptable alternative to the traditional 
6 weeks regime. 
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Purpose/Objective: Functional imaging is known as accurate tool for 
evaluation of chemotherapy (CHT) efficacy in patients (pts) with 
breast cancer (BC). We determine the group of patients with excellent 
functional response to neoadjuvant chemotherapy as a potential 
candidates for breast irradiation instead of mastectomy. 
Materials and Methods: 50 primary pts with advanced BC (T3-4, N1-2) 
were included in this study. Breast scintigraphy (BS) was done before 
the start of CHT and after 2-6 cycles of treatment with taxane-
doxorubicin based regimes ± trastuzumab. BS was performed 10-15 
min after i/v injection of 740 MBq of 99mTc-MIBI. Qualitative and 
semiquantitative scores were used to qualify dynamic of tracer uptake 
